Search for a command to run...
Every processed story in chronological order, with the newest coverage first. Filter by tag, source, or score to drill in.
Practitioners building AI tools for biotech should note that TARIO-2's ability to extract rich tumor biology from a universally available assay (H&E) — and GSK's willingness to license it as a platform — signals a viable commercial path for AI software in drug development beyond the typical pivot to in-house drug discovery.